AIDSinfo - Drug Details

A Service of The U.S. Department of Health
and Human Services

Antiretroviral Drugs

Fusion Inhibitors

Enfuvirtide (Fuzeon, T-20)

Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Delavirdine (Rescriptor)

Efavirenz (Sustiva)

Nevirapine (Viramune)

Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Abacavir (Ziagen)

Abacavir + Lamivudine (Epzicom)

Abacavir+Lamivudine+Zidovudine (Trizivir)

Didanosine (Videx, ddI)

Emtricitabine (Emtriva, FTC)

Emtricitabine + Tenofovir DF (Truvada)

Lamivudine (Epivir, 3TC)

Lamivudine+Zidovudine (Combivir)

Stavudine (Zerit, d4T)

Tenofovir DF (Viread)

Zalcitabine (Hivid, ddC)

Zidovudine (Retrovir, AZT, ZDV)

Protease Inhibitors (PIs)

Amprenavir (Agenerase)

Atazanavir (Reyataz)

Fosamprenavir (Lexiva, 908)

Indinavir (Crixivan)

Lopinavir+Ritonavir (Kaletra)

Nelfinavir (Viracept)

Ritonavir (Norvir)

Saquinavir (Fortovase, Invirase)

Home > Drugs > Reyataz

Atazanavir (Reyataz)

Generic Name: Atazanavir
Brand Name: Reyataz

Atazanavir, also known as Reyataz, is a type of antiretroviral medicine called a protease inhibitor (PI). These medicines block protease, a protein that HIV needs to make more copies of itself.

AIDSinfo Drug Record for Atazanavir

Search the Drug Database

Guidelines References to Atazanavir

	Adult and Adolescent Guidelines
	Table 12a: Antiretroviral Regimens Recommended for Treatment of HIV-1 Infection in Antiretroviral Naïve Patients
	Table 12b: Advantages and Disadvantages of Antiretroviral Components Recommended as Initial Antiretroviral Therapy
	Table 13: Antiretroviral Dosing Recommendations for Patients with Renal or Hepatic Dysfunction
	Table 14: Antiretroviral Regimens or Components That Should Not Be Offered At Any Time
	Table 17: Characteristics of Protease Inhibitors (PIs)
	Table 20: Drugs That Should Not Be Used With PI or NNRTI Antiretrovirals
	Table 21: Drug Interactions Between Antiretrovirals and Other Drugs: PIs, NNRTIs, and NRTIs
	Table 22a: Drug Effects on Blood Concentration of PIs
	Table 22b: Drug Effects on Blood Concentration of NNRTIs
	Table 30: Preclinical and Clinical Data Concerning the Use of Antiretrovirals During Pregnancy
	Pediatric Guidelines
	Appendix: Characteristics of Available Antiretroviral Drugs
	PI Drugs - Pediatrics
	Supplement: Pediatric Antiretroviral Drug Information
	Table 10: Advantages and Disadvantages of PIs for Use in Highly Active Antiretroviral Combination Regimens
	Table 11: Recommended Antiretroviral Regimens for Initial Therapy for HIV Infection in Children
	Perinatal Guidelines
	PI Drugs - Perinatal
	Table 2: Preclinical and Clinical Data Relevant to the Use of Antiretrovirals During Pregnancy
	Table 3: Antiretroviral Drug Use in Pregnant HIV-Infected Women: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy

Atazanavir News

	FDA Approves a Once Daily Protease Inhibitor for HIV Infection
	more...

More About Atazanavir

	AIDSinfo Drug Record for Atazanavir
	MEDLINEplus Fact Sheet on Atazanavir
	Clinical Trials using Atazanavir
	Literature Citations for Atazanavir
	more...